Skip to main content

Table 1 Anticholinergic drugs with concordant ratings of sores

From: An anticholinergic burden score for German prescribers: score development

Drug

ATC-Code

Carnahan 2006 USA [20]

Ancelin 2006 France [21]

Rudolph 2008 USA [22]

Han 2008 USA [23]

Ehrt 2010 Norway modified [24]

Sittironnarit 2011 Australia [26]

Boustani 2012 USA [40]

Duran 2013 [18]

Weak anticholinergic effects ACB score 1

 Ampicillin

J01CA01

1

      

0 or 1

 Aripiprazole

N05AX12

     

0

1

 

 Atenolol

C07AB03

0

  

1

0

0

1

0

 Azathioprine

L04AX01

1

      

0 or 1

 Benazepril

C09AA07

0

  

1

   

0 or 1

 Betaxolol

C07AB05

   

1

 

0

 

0 or 1

 Bisacodyl

A06AB02

0

    

1

 

0 or 1

 Bromocriptine

N04 BC01

1

   

0

  

weak(1–2)

 Bupropion

N06AX12

0

  

1

  

1

0 or 1

 Captopril

C09AA01

1

   

0

0

1

0 or 1

 Celecoxib

M01AH01

0

    

1

 

0 or 1

 Chlordiazepoxide

N05BA02

1

  

1

   

weak(1–2)

 Chlorthalidone

C03BA04

1

    

0

1

0 or 1

 Ciclosporin

L04 AD01

1

      

0 or 1

 Citalopram

N06AB04

0

   

1

1

 

weak(1–2)

 Clindamycin

J01FF01

1

      

0 or 1

 Clonazepam

N03AE01

1

    

1

 

weak(1–2)

 Dexamethasone

H02AB02

1

    

0

 

0 or 1

 Dextromethorphan

R05DA09

0

  

1

   

0 or 1

 Diazepam

N05BA01

1

  

1

1

1

1

weak(1–2)

 Digitoxin

C01AA04

1

   

1

  

weak(1–2)

 Diltiazem

C08DB01

1

    

0

 

0 or 1

 Dipyridamole

B01AC07

1

   

0

 

1

0 or 1

 Domperidone

A03FA03

     

1

 

weak(1–2)

 Entacapone

N04BX02

0

 

1

    

weak(1–2)

 Escitalopram

N06AB10

0

    

1

 

0 or 1

 Famotidine

A02BA03

1

    

0

 

0 or 1

 Fentanyl

N02AB03

1

     

1

weak(1–2)

 Flunitrazepam

N05CD03

    

1

  

0 or 1

 Fluoxetine

N06AB03

1

  

1

1

1

 

weak(1–2)

 Flurazepam

N05CD01

1

      

0 or 1

 Fluvoxamine

N06AB08

1

   

1

1

1

weak(1–2)

 Gentamicin

J01GB03

1

      

0 or 1

 Guaifenesin

R05CA03

0

  

1

   

0 or 1

 Hydralazine

C02DB02

1

    

0

1

0 or 1

 Hydrocortisone

H02AB09

1

     

1

0 or 1

 Isosorbide dinitrate

C01DA08

1

   

0

0

 

0 or 1

 Isosorbide mononitrate

C01DA14

1

    

0

 

0 or 1

 Ketorolac

M01AB15

   

1

   

weak(1–2)

 Lansoprazole

A02BC03

0

   

1

0

 

0 or 1

 Levodopa

N04BA01

0

 

1

1

0

0 or 1

 

0 or 1

 Lithium

N05AN01

0

    

1

 

weak(1–2)

 Lorazepam

N05BA06

1

      

0 or 1

 Metformin

A10BA02

0

    

1

 

0 or 1

 Methotrexate

L04AX03

0

    

1

 

0 or 1

 Methylprednisolone

H02AB04

1

    

0

 

0 or 1

 Metoprolol

C07AB02

0

  

1

0

0

1

0

 Midazolam

N05CD08

1

      

0 or 1

 Mirtazapine

N06AX11

0

 

1

    

weak(1–2)

 Morphine

N02AA01

1

  

1

  

1

weak(1–2)

 Naratriptan

N02CC02

     

1

 

0 or 1

 Nifedipine

C08CA05

1

   

0

0

1

0

 Oxazepam

N05BA04

1

   

0

1

 

0 or 1

 Oxycodone

N02AA05

1

  

1

 

1

 

weak(1–2)

 Pancuronium

M03 AC01

1

      

0 or 1

 Phenobarbital

N03AA02

0

  

1

1

  

0 or 1

 Piperacillin

J01CA12

1

      

0 or 1

 Pramipexole

N04 BC05

0

 

1

 

0

  

0 or 1

 Prednisolone

A07EA01

1

   

0

0

 

0 or 1

 Prednisone

A07EA03

1

     

1

 

 Quinidine

C01BA01

0

     

1

 

 Risperidone

N05AX08

0

 

1

1

 

1

1

weak(1–2)

 Selegiline

N04BD01

0

 

1

 

0

  

0 or 1

 Sertraline

N06AB06

1

  

1

0

0

 

0

 Sumatriptan

N02CC01

     

1

 

0 or 1

 Temazepam

N05CD07

1

    

1

 

weak(1–2)

 Trandolapril

C09AA10

0

  

1

 

0

 

0 or 1

 Trazodone

N06AX05

0

 

1

1

  

1

weak(1–2)

 Triamcinolone

H02AB08

1

    

0

 

0 or 1

 Triamterene

C03DB02

1

    

0

1

0 or 1

 Triazolam

N05CD05

1

  

1

   

weak(1–2)

 Valproic acid

N03AG01

1

    

0

 

0 or 1

 Vancomycin

J01XA01

1

      

0 or 1

 Venlafaxine

N06AX16

0

  

1

0

1

1

0

 Warfarin

B01AA03

1

   

0

0

1

0

 Ziprasidone

N05AE04

  

1

    

0 or 1

 Zolmitriptan

N02CC03

     

1

 

0 or 1

Moderate anticholinergic effects ACB score 2

 Amantadine

N04BB01

1

 

2

   

2

weak(1–2)

 Cimetidine

A02BA01

2

 

2

   

1

weak(1–2)

 Loperamide

A07DA03

1

 

2

1

 

1

1

weak(1–2)

 Loxapine

N05AH01

2

     

2

weak(1–2)

 Methadone

N07 BC02

   

2

   

weak(1–2)

 Oxcarbazepine

N03AF02

2

     

2

weak(1–2)

 Pimozide

N05AG02

2

     

2

weak(1–2)

 Ranitidine

A02BA02

2

 

1

2

1

1

1

weak(1–2)

 Theophylline

R03DA04

1

2

  

1

2

1

weak(1–2)

 Tramadol

N02AX02

1

  

2

 

2

 

weak(1–2)

Strong anticholinergic effects ACB score 3

 Amitriptyline

N06AA09

3

3

3

3

3

3

3

Strong(3)

 Atropine

A03BA01

3

 

3

3

 

3

3

Strong(3)

 Chlorpheniramine

R06AB04

3

3

3

3

 

3

3

Strong(3)

 Clemastine

R06AA04

3

     

3

Strong(3)

 Clomipramine

N06AA04

3

3

    

3

Strong(3)

 Clozapine

N05AH02

3

 

2

 

3

 

3

Strong(3)

 Cyproheptadine

R06AX02

2

 

3

  

3

2

Strong(3)

 Darifenacin

G04BD10

3

     

3

Strong(3)

 Dimenhydrinate

A04AB02

3

     

3

Strong(3)

 Diphenhydramine

A04AB05

3

 

3

3

  

3

Strong(3)

 Doxepin

N06AA12

3

  

3

3

3

3

Strong(3)

 Flavoxate

G04BD02

3

     

3

Strong(3)

 Hydroxyzine

N05BB01

3

3

3

   

3

Strong(3)

 Imipramine

N06AA02

3

3

3

3

 

3

3

Strong(3)

 Levomepromazine

N05AA02

2

3

    

2

Strong(3)

 Nortriptyline

N06AA10

3

 

2

3

2

 

3

Strong(3)

 Orphenadrine

N04AB02

3

3

  

3

 

3

Strong(3)

 Oxybutynin

G04BD04

3

3

3

 

3

2

3

Strong(3)

 Procyclidine

N04AA04

3

      

Strong(3)

 Scopolamine

A04AD01

3

  

3

  

3

Strong(3)

 Thioridazine

N05 AC02

3

 

3

3

3

 

3

Strong(3)

 Tizanidine

M03BX02

  

3

    

Strong(3)

 Tolterodine

G04BD07

3

 

2

3

 

3

3

Strong(3)

 Trihexyphenidyl

N04AA01

3

3

 

3

3

 

3

Strong(3)

 Trimipramine

N06AA06

3

3

  

3

 

3

Strong(3)

  1. Drugs are sorted by their assigned score and then alphabetical